allograft

(redirected from allograft rejection)
Also found in: Thesaurus, Medical, Encyclopedia.

al·lo·graft

 (ăl′ə-grăft′)
n.
A tissue or organ graft between genetically different individuals of the same species, as between two humans. Also called homograft.

al′lo·graft′ v.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

allograft

(ˈæləʊˌɡrɑːft)
n
(Medicine) a tissue graft from a donor genetically unrelated to the recipient
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

al•lo•graft

(ˈæl əˌgræft, -ˌgrɑft)

n.
a tissue or organ obtained from one member of a species and grafted to a genetically dissimilar member of the same species. Also called homograft.
[1960–65]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.allograft - tissue or organ transplanted from a donor of the same species but different genetic makeupallograft - tissue or organ transplanted from a donor of the same species but different genetic makeup; recipient's immune system must be suppressed to prevent rejection of the graft
graft, transplant - (surgery) tissue or organ transplanted from a donor to a recipient; in some cases the patient can be both donor and recipient
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

al·lo·graft

n. aloinjerto. V.: homograft.
English-Spanish Medical Dictionary © Farlex 2012

allograft

n aloinjerto
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Thus, the objective of the treatment is to optimize the immunosuppressive dose in order to eradicate the virus while preventing allograft rejection; in some cases, antiviral therapies can be provided.
29 patients received a heart transplantation with complications including allograft rejection leading to re-transplant, muscle weakness and respiratory failure that required mechanical ventilatory support.
According to Natera, its organ transplant rejection assay is designed to detect active allograft rejection in patients who have undergone kidney transplantation.
TGF-[beta]1 is believed to have a positive impact on liver allograft rejection and on the survival time of recipients in the models of OLT rats.
TIM-3 is a type I membrane protein preferentially expressed on terminally differentiated Th1 cells, which seems to be central in the mechanisms of allograft rejection (15).
The most frequently observed activity in allograft rejection is T cell-mediated reaction.
In accordance with this finding, CD68+ macrophages were found in the infiltrate of hepatic lobules in acute liver allograft rejection and the number of infiltrating cells correlated with the severity of the ACR in a previous report [28].
Importantly, no patient suffered allograft rejection, nor graft dysfunction (such as might be seen with antibody mediated rejection).
Moreover, due to the progression of allograft immunology, some new types of immunosuppressive agents and therapy are used and that have prevented or reversed acute allograft rejection effectively in the past 20 years, which lead to the short-term (1-year) allograft survival time of 88-95% [1].
Antibody-mediated renal allograft rejection (ABMR) is a major cause of late allograft dysfunction and graft loss [1-3].
Acute rejection was assessed by endomyocardial biopsy (EMB) and was defined according to the International Society for Heart and Lung Transplantation grading system for acute cardiac allograft rejection [14].
Sensitization with donor-specific antibodies (DSA) to Human Leukocyte Antigen (HLA) has been shown to increase the risk of accelerated solid organ allograft rejection and loss [1].